The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019. Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region.
The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014.
Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years.
The report has profiled the leading players of this market, along with the developments (New product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the European sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (Netherlands); ResMed (U.S.); Compumedics Limited (Australia); Carefusion Corporation (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Itamar Medical, Ltd. (U.S.); and Weinmann Medical Devices GmbH & Co. KG (Germany) are among the key players operational in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together provide basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the European sleep apnea devices market, high-growth regions, countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the market.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater share in the market. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
Product Analysis and development: Detailed insights on upcoming technologies, research & development activities, and new product launches in the European sleep apnea devices market, along with usage patterns/penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data. This analysis also includes a comprehensive coverage of product approvals, patent analysis, pipeline products, and product recalls.
Market Development: Comprehensive information about lucrative emerging markets, through analysis conducted across the criteria of geographies, distribution channels, clientele base, and different pricing policies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the sleep apnea devices market, along with a detailed description regarding the related and unrelated diversification pertaining to this market
Epidemiology Data: The incidences and patient pool of Obstructive Sleep Apnea (OSA)
Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2019, along with details of the strategies and manufacturing capabilities of the leading players in the sleep apnea devices market
Product/Brand Perception Analysis: A comprehensive study of customers’ perceptions and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs